|
Clinical Characteristics
|
Unidentified group I
|
rotavirus group II
|
E. histolytica group III
|
adenovirus group IV
|
Mixed group V
|
Total
|
P-value
|
|---|
|
Frequency (%)
|
287 (46.4%)
|
84 (13.6%)
|
172 (27.8%)
|
38 (6.1%)
|
38 (6.1%)
|
619
|
–
|
|
Clinical Manifestations
|
|
Fever
|
215 (74.9%)
|
52 (61.9%)
|
143 (83.1%)
|
22 (57.9%)
|
26 (68.4%)
|
458
|
0.001
|
|
Vomiting
|
112 (39.0%)
|
53 (63.1%)
|
66 (38.4%)
|
22 (57.9%)
|
24 (63.2%)
|
277
|
0.000
|
|
Diarrhea
|
208 (72.5%)
|
69 (82.1%)
|
144 (83.7%)
|
33 (86.8%)
|
29 (76.3%)
|
483
|
0.016
|
|
Vesikari score (Mean ± SD)
|
11.2 ± 1.8
|
11.4 ± 1.5
|
11.8 ± 1.6
|
11.2 ± 1.6
|
11.3 ± 1.8
|
–
|
0.005
|
|
Duration of hospitalization per days (Mean ± SD)
|
2.7 ± 1.2
|
2.9 ± 1.1
|
2.9 ± 1.2
|
3.3 ± 2.1
|
3.4 ± 1.3
|
3.04a
|
0.003
|
|
Laboratory Findings
|
|
WBCs (× 103 per mm3)
|
2.79 ± 3.85
|
2.29 ± 3.04
|
12.23 ± 4.98
|
1.92 ± 2.29
|
7.15 ± 6.76
|
–
|
0.000
|
|
RBCs (million per mm3)
|
1.47 ± 1.88
|
1.53 ± 2.06
|
7.10 ± 5.45
|
1.14 ± 1.01
|
3.19 ± 3.99
|
–
|
0.000
|
|
HGB (in mg/dL; mean ± SD)
|
11.7 ± 2.4
|
11.5 ± 1.2
|
12.6 ± 8.4
|
12.1 ± 1.0
|
11.5 ± 1.1
|
–
|
0.008
|
|
HCT (in %; mean ± SD)
|
33.5 ± 4.1
|
33.9 ± 3.2
|
34.0 ± 4.2
|
34.8 ± 4.7
|
34.1 ± 2.9
|
–
|
0.027
|
|
BS (in mg/dL; mean ± SD)
|
91.1 ± 28.3
|
77.1 ± 20.1
|
97.5 ± 19.2
|
86.0 ± 27.7
|
87.3 ± 19.1
|
–
|
0.000
|
|
CRP (in mg/dL; mean ± SD)
|
49.5 ± 65.9
|
28.0 ± 61.4
|
66.3 ± 67.4
|
11.7 ± 20.0
|
43.7 ± 85.9
|
–
|
0.000
|
- Abbreviations: WBCs White blood cells, RBCs Red blood cells, HGB Hemoglobin, HCT Hematocrit, BS Blood sugar, CRP C-reactive protein
- aMean of the five groups; significant p-values are made bold
